Status:
TERMINATED
Intrathecal Hydromorphone for Labor Analgesia
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Pregnancy
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturie...
Eligibility Criteria
Inclusion
- Patients are eligible for enrollment if they are healthy, pregnant females between the ages of 18 and 45 years, primiparous, and at term gestation (≥ 37 weeks).
Exclusion
- Patients with a Category II or III fetal heart rate tracing, a fetus with intrauterine growth restriction, prolonged rupture of membranes, recent diagnosis of infection of any cause, or in whom dural puncture is contraindicated will be excluded from the study.
Key Trial Info
Start Date :
September 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT02277782
Start Date
September 1 2015
End Date
December 31 2019
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115